Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 15, 2024Blood Cancer JournalOpen Access

Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme

View Full Paper
Ask AI
Bookmark
Share

Authors

MEMacarena Oporto EspuelasGreat Ormond Street HospitalSBSaskia BurridgeGreat Ormond Street HospitalAKAmy A. KirkwoodCancer Research UK

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Espuelas et al. (2024) studied this question.

synapsesocial.com/papers/68e6f04eb6db64358766b20ehttps://doi.org/10.1038/s41408-024-01038-2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Current concepts in the diagnosis and management of cytokine release syndrome2014 · 2,855 citations
  2. 2Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report2021 · 84 citations
  3. 3INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic Leukemia2023 · 11 citations
  4. 4CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL2023 · 93 citations